SUBSCRIBE
3 minutes
Kelvin Capital has led a £2m funding round for biotech business ProFactor Pharma to accelerate its work in developing a treatment for Haemophilia A. Kelvin Capital led the funding round, supported by Ingenza Ltd and the Scottish Investment Bank, the investment arm of Scottish Enterprise.
